Immune Response News and Research

RSS

Researchers identify a bivalent histone-mark switch essential for angiogenesis

Defying conventional epigenomic wisdom, the non-conventional polycomb (PRC)1 variant paradoxically overwhelms the conventional PRC-mediated gene silencing in activated endothelial cells.

8 Feb 2022

Study shows how gut bacteria could undermine immunity in pancreatic cancer

Researchers at the University of Toronto and University Health Network have shown how probiotic bacteria in the gut could undermine immunity in pancreatic cancer, pointing toward more personalized cancer treatments.

8 Feb 2022

The B and T cell responses to SARS-CoV-2

Researchers assess the correlation between humoral and cell-mediated responses to SARS-CoV-2 in symptomatic and asymptomatic individuals.

8 Feb 2022

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

The new study uses PCR data on 17 different pathogens, collected from clinical samples as part of the Seattle Flu Study, a community-based surveillance study of respiratory viral infections.

8 Feb 2022

Reanalysis of the efficacy of COVID-19 vaccines

In a new study, researchers investigated the impact of trial study design and other parameters on the estimates of COVID-19 vaccine efficacy.

8 Feb 2022

Fever the dominant symptom in SARS-CoV-2 Alpha- and Delta-infected children

Researchers assess the different clinical symptoms of SARS-CoV-2 infection in children and adolescents across different time periods.

7 Feb 2022

mRNA-based COVID-19 booster vaccination shown to protect against severe omicron infection in macaques

Scientists recently evaluated the effectiveness of a booster dose of the Moderna-developed COVID-19 vaccine and omicron spike-specific mRNA vaccine in non-human primates that are primed with the Moderna vaccine.

7 Feb 2022

Colchicine holds promise to reduce the risk of severe COVID-19

A recent article, published in Rheumatology and Therapy, reviews the potent evidence of colchicine against the SARS-CoV-2 infection.

7 Feb 2022

Researchers develop 3D human spinal cord implants for treating paralyzed patients

For the first time in the world, researchers from Sagol Center for Regenerative Biotechnology at Tel Aviv University have engineered 3D human spinal cord tissues and implanted them in lab model with long-term chronic paralysis.

7 Feb 2022

Evaluating delayed vaccination schedules for protection against SARS-CoV-2

Researchers conducted an observational study to compare the humoral and cellular responses in health care workers who had received two doses of the Pfizer-BioNTech vaccine at standard (3 to 6 weeks) and delayed (8 to 16 week) intervals.

7 Feb 2022

Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation

A new article reviewed the innate immune detection and signaling pathways that the host uses against SARS-CoV-2.

7 Feb 2022

Women, smokers and drinkers more likely to develop taste or smell disorders from COVID

Researchers investigate the relationship between TSD and COVID-19.

6 Feb 2022

Developing injectable granular hydrogels for brain regeneration and function recovery after stroke

The Centers for Disease Control and Prevention estimate that someone in the United States has a stroke every 40 seconds.

4 Feb 2022

Scientists elucidate the structure of central cellular inflammatory switch

Researchers at the Universities of Bonn and Regensburg have elucidated the structure of a central cellular inflammatory switch.

4 Feb 2022

Wistar researchers takes a promising step in the direction of developing HIV vaccine

Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, takes a promising step in the direction of developing an HIV vaccine.

4 Feb 2022

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

In a new study, a team of researchers developed a hybrid vaccine for SARS-CoV-2 and influenza viruses using influenza virus-like particles (VLP).

4 Feb 2022

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

In a new study, a team of researchers assessed the affinity of the SARS-CoV-2 Omicron variant of concern towards major histocompatibility complex (MHC) binding

4 Feb 2022

Study shows SARS-CoV-2 infection can change nasopharyngeal microbiota composition in pregnancy

A recent study from Spain showed that the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can change the overall structure and diversity of the nasopharyngeal microbiota in pregnant women – which persists even weeks after clinical infection. The paper is currently available on Research Square preprint* server.

3 Feb 2022

Roswell Park scientists identify a potential new treatment target for pancreatic cancer

Scientists at Roswell Park Comprehensive Cancer Center have identified a potential new target for the treatment of pancreatic cancer.

3 Feb 2022

CRISPRa method helps discover genes that play a role in immune cell biology

CRISPR genome editing has served as a powerful tool for deleting or altering DNA sequences and studying the resulting effect.

3 Feb 2022

Immune Response News and Research

Researchers identify a bivalent histone-mark switch essential for angiogenesis

Study shows how gut bacteria could undermine immunity in pancreatic cancer

The B and T cell responses to SARS-CoV-2

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

Reanalysis of the efficacy of COVID-19 vaccines

Fever the dominant symptom in SARS-CoV-2 Alpha- and Delta-infected children

mRNA-based COVID-19 booster vaccination shown to protect against severe omicron infection in macaques

Colchicine holds promise to reduce the risk of severe COVID-19

Researchers develop 3D human spinal cord implants for treating paralyzed patients

Evaluating delayed vaccination schedules for protection against SARS-CoV-2

Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation

Women, smokers and drinkers more likely to develop taste or smell disorders from COVID

Developing injectable granular hydrogels for brain regeneration and function recovery after stroke

Scientists elucidate the structure of central cellular inflammatory switch

Wistar researchers takes a promising step in the direction of developing HIV vaccine

Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

Study shows SARS-CoV-2 infection can change nasopharyngeal microbiota composition in pregnancy

Roswell Park scientists identify a potential new treatment target for pancreatic cancer

CRISPRa method helps discover genes that play a role in immune cell biology

Understanding the DNA Damage Response in Innate Immunity eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News